Primobolan Depot has a reputation as a 'calm' steroid that supposedly does not affect mood. The editorial team checked what is known about the effects of androgens on the psyche: how mood, aggressiveness and sleep change during use and after withdrawal, and who is at especially high risk.
Androgens and the brain: basic mechanisms
Androgen receptors are present not only in the muscles and reproductive organs but also in many areas of the brain: the amygdala, hypothalamus, hippocampus and prefrontal cortex. These very structures are involved in regulating emotions, aggression, motivation, memory and sleep.
Methenolone is a derivative of dihydrotestosterone that acts on androgen receptors but does not convert into estradiol. This is an important detail, because part of testosterone's effects on the brain, in particular on libido and mood, are mediated in men precisely by estrogens produced locally in nervous tissue.
During the use of any exogenous androgen, one's own testosterone is suppressed. In the case of non-aromatizing methenolone this means that estradiol levels may also decline. Therefore the psycho-emotional profile on primobolan potentially differs from that of testosterone, although no direct comparative studies exist.
No direct clinical studies of the mental effects of methenolone enanthate have been conducted. Everything we know is based on data about anabolic steroids in general, and the editorial team clearly distinguishes established facts from assumptions.
Mood: from euphoria to depression
The best-controlled study of the mental effects of supraphysiological doses of androgens is the randomized placebo-controlled trial by Pope, Kouri and Hudson (2000), published in Archives of General Psychiatry. Healthy men received testosterone cypionate in doses that substantially exceeded physiological levels.
The result proved heterogeneous: in most participants mood changes were minimal, but a small proportion developed noticeable hypomanic or manic symptoms - elevated mood, irritability, reduced need for sleep, impulsivity. This points to an individual vulnerability that is difficult to predict in advance.
The opposite pole is depressive states, which most often arise after discontinuing the drugs. Reviews by Kanayama and colleagues (2008) describe a withdrawal syndrome with depressed mood, fatigue, reduced libido, insomnia and, in severe cases, suicidal thoughts. This condition is linked to hypogonadism after suppression of the hormonal axis.
A systematic review by Piacentino and colleagues (2015) confirmed the association between the use of anabolic steroids and a range of psychopathological manifestations, although it noted that cause-and-effect relationships are difficult to establish because of the characteristics of the studied groups.
Aggression: the myth of 'steroid rage' and the real data
The popular image of 'steroid rage' oversimplifies reality. Most people do not become aggressive under the influence of androgens. However, studies indicate that in some users irritability and a tendency toward conflict increase, especially at high doses and combinations of drugs.
The scientific review by the Endocrine Society (Pope et al., 2014) summarizes: a link between anabolic steroids and aggressive behavior exists, but it is modulated by many factors - personality traits, alcohol and other substance use, social environment, a history of mental disorders.
Regarding methenolone, there is a widespread belief in the sports community that it is 'calm' and does not cause aggression. There are no scientific data that would confirm or refute this claim. One can only say that its lower androgenic activity compared with some other drugs could theoretically also mean less pronounced behavioral changes, but this is an assumption.
Practically important: if those close to you notice behavioral changes - outbursts of anger, impatience, conflict-proneness - this is a serious signal, even if the person themselves is not aware of them.
Sleep: what happens to night-time rest
Sleep and androgens are linked in both directions. On the one hand, sufficient sleep is necessary for the normal production of one's own testosterone, whose secretion peaks in the morning hours. On the other, exogenous androgens can disrupt sleep architecture.
| Problem | Possible link to androgens | What to do |
|---|---|---|
| Insomnia, shallow sleep | Described by users of various steroids; may be part of hypomanic changes | Sleep hygiene; for persistent insomnia - a doctor |
| Obstructive sleep apnea | A known risk of testosterone therapy; worsens with an increase in body and neck mass | Assessment of snoring, daytime sleepiness, polysomnography |
| Sleep disturbances after withdrawal | Part of the withdrawal syndrome linked to hypogonadism and lowered mood | Hormone monitoring, consultation with a specialist |
| Night sweats, tachycardia | Possible when combined with other drugs or stimulants | Blood pressure check, ECG |
Sleep apnea deserves separate attention. It raises blood pressure, the risk of arrhythmias and daytime sleepiness, and in combination with the elevated hematocrit seen with androgens it creates a serious burden on the cardiovascular system. Loud snoring with breathing pauses is a reason to see a sleep specialist.
An additional factor is stimulants, which are often combined with 'cutting' drugs, a category that includes primobolan. Caffeine, synephrine and other stimulants taken in the evening substantially worsen falling asleep.
The editorial team reminds you: chronic sleep deprivation in itself lowers mood and increases irritability, so sleep problems and psycho-emotional changes often reinforce one another.
Dependence and risk groups
Anabolic steroids do not cause the classic euphoria of narcotic substances, but dependence on them has been described. According to Kanayama and colleagues (2008), some users develop a persistent need to continue use despite harm - out of fear of losing their form, rejection of their own body, or unpleasant withdrawal symptoms.
- Muscle dysmorphia:a constant feeling of 'insufficient' musculature that fuels continued use.
- History of mental disorders:bipolar disorder, depression and anxiety disorders increase the risk of complications.
- Combination with alcohol and drugs:increases impulsivity and the risk of severe consequences.
- Young age:a still-developing brain may be more vulnerable to hormonal changes.
For people in these groups, any hormonal drugs carry an increased psychiatric risk, regardless of the reputation of the specific substance.
If you notice persistent depressed mood, anxiety, insomnia or thoughts of self-harm in yourself, consult a doctor or psychologist. In a crisis situation you should seek emergency help immediately.
Editorial conclusions
There are no direct studies of the effect of Primobolan Depot on the psyche; the data are based on knowledge of androgens as a class.
In most people there are no pronounced mood changes, but some may experience hypomanic symptoms during use and depressive ones after withdrawal. Aggression depends on dose, combinations, personality and alcohol use.
Sleep can be disrupted both directly and through apnea and stimulants, and sleep deprivation worsens psycho-emotional problems.
We also recommend reading our materials on the effect of Primobolan Depot on the kidneys, skin and hair.
References
- Pope HG Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000;57(2):133–140.
- Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008;98(1–2):1–12.
- Piacentino D, Kotzalidis GD, Del Casale A, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015;13(1):101–121.
- Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
- Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521.
- World Anti-Doping Agency. The Prohibited List: International Standard (S1.1 Anabolic androgenic steroids). Montreal: WADA; чинна редакція.
Andriy Melnyk
A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.
